Lung cancer screening: Current status and perspective - 14/10/16
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
Lung cancer screening by low-dose computed tomography (CT) has been proven to reduce lung cancer-related mortality by 20%, in the National Lung cancer Screening Trial (NLST). Low-dose CT acquisition protocols should result in effective dose not exceeding 1.5mSv, and should be read by radiologists who have an expertise in the field. A volumetry-based approach similar to that used in the NELSON study allows reducing the rate of positive screens around 2%. The major harm of screening is overdiagnosis, which correspond to the detection of indolent tumours that would not cause the subject death. Ongoing research for the development of useful biomarkers to be combined to imaging could improve the accuracy of lung cancer screening.
Le texte complet de cet article est disponible en PDF.Keywords : Lung, Screening, Lung cancer, Computed tomography
Plan
Vol 97 - N° 10
P. 949-953 - octobre 2016 Retour au numéro
Article précédent
- Combatting lung cancer: Advances in imaging on all fronts
- E. Coche
- Lung adenocarcinomas: correlation of computed tomography and pathology findings
- J.G. Cohen, E. Reymond, A. Jankowski, E. Brambilla, F. Arbib, S. Lantuejoul, G.R. Ferretti
Bienvenue sur EM-consulte, la référence des professionnels de santé.